Yuqian Cui1, Yuhua Shi2, Linlin Cui2, Ting Han2, Xuan Gao2, Zi-Jiang Chen3. 1. Center for Reproductive Medicine, Provincial Hospital Affiliated with Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Key Laboratory for Reproductive Endocrinology of the Ministry of Education; and Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, People's Republic of China; Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, People's Republic of China. 2. Center for Reproductive Medicine, Provincial Hospital Affiliated with Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Key Laboratory for Reproductive Endocrinology of the Ministry of Education; and Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, People's Republic of China. 3. Center for Reproductive Medicine, Provincial Hospital Affiliated with Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Key Laboratory for Reproductive Endocrinology of the Ministry of Education; and Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, People's Republic of China; Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, People's Republic of China. Electronic address: chenzijiang@hotmail.com.
Abstract
OBJECTIVE: To determine the serum antimüllerian hormone (AMH) reference values in Chinese women with and without polycystic ovary syndrome (PCOS), and the associations of AMH with clinical or biochemical characteristics. DESIGN: Retrospective study. SETTING: Academic institutions. PATIENT(S): Totals of 1,896 infertile control women and 304 women with PCOS. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum basal AMH levels and clinical, endocrine, and metabolic parameters. RESULT(S): In the same age group, serum AMH levels were higher in PCOS women than those without PCOS. AMH levels were not significantly related to indices of insulin resistance or metabolic-related variables in both groups. In the infertile control group, AMH increased with antral follicle count (AFC) and LH and decreased with age, body mass index (BMI), and FSH. In the PCOS group, AMH levels showed positive correlations with LH, AFC, and T and negative correlations with BMI. The median AMH levels were 2.35 ng/mL for ages 20-31 years, 1.58 ng/mL for ages 32-34 years, 1.30 ng/mL for ages 35-37 years, 0.96 ng/mL for ages 38-40 years, 1.05 ng/mL for ages 41-43 years, and 0.67 ng/mL for ages>43 years in the control group and 4.38 ng/mL for ages 20-31 years, 3.47 ng/mL for ages 32-34 years, and 3.30 ng/mL for ages 35-37 years in the PCOS group. CONCLUSION(S): This study determined reference values of serum AMH in Chinese women with and without PCOS. Elevated serum AMH levels do not affect the risk of insulin resistance or metabolic syndrome.
OBJECTIVE: To determine the serum antimüllerian hormone (AMH) reference values in Chinese women with and without polycystic ovary syndrome (PCOS), and the associations of AMH with clinical or biochemical characteristics. DESIGN: Retrospective study. SETTING: Academic institutions. PATIENT(S): Totals of 1,896 infertile control women and 304 women with PCOS. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum basal AMH levels and clinical, endocrine, and metabolic parameters. RESULT(S): In the same age group, serum AMH levels were higher in PCOSwomen than those without PCOS. AMH levels were not significantly related to indices of insulin resistance or metabolic-related variables in both groups. In the infertile control group, AMH increased with antral follicle count (AFC) and LH and decreased with age, body mass index (BMI), and FSH. In the PCOS group, AMH levels showed positive correlations with LH, AFC, and T and negative correlations with BMI. The median AMH levels were 2.35 ng/mL for ages 20-31 years, 1.58 ng/mL for ages 32-34 years, 1.30 ng/mL for ages 35-37 years, 0.96 ng/mL for ages 38-40 years, 1.05 ng/mL for ages 41-43 years, and 0.67 ng/mL for ages>43 years in the control group and 4.38 ng/mL for ages 20-31 years, 3.47 ng/mL for ages 32-34 years, and 3.30 ng/mL for ages 35-37 years in the PCOS group. CONCLUSION(S): This study determined reference values of serum AMH in Chinese women with and without PCOS. Elevated serum AMH levels do not affect the risk of insulin resistance or metabolic syndrome.
Authors: Julie S Rios; Eleni A Greenwood; Mary Ellen G Pavone; Marcelle I Cedars; Richard S Legro; Michael P Diamond; Nanette Santoro; Fangbai Sun; Randal D Robinson; Gregory Christman; Heping Zhang; Heather G Huddleston Journal: J Clin Endocrinol Metab Date: 2020-01-01 Impact factor: 5.958
Authors: A Bothou; N Koutlaki; G Iatrakis; G Mastorakos; P Tsikouras; V Liberis; G Galazios; A Liberis; A Lykeridou; S Zervoudis Journal: Acta Endocrinol (Buchar) Date: 2017 Apr-Jun Impact factor: 0.877
Authors: Ali Şahin; Savaş Karakuş; Yunus Durmaz; Çağlar Yıldız; Hüseyin Aydın; Ahmet Kıvanç Cengiz; Duygu Güler Journal: Int J Rheumatol Date: 2015-05-12
Authors: B Meczekalski; A Czyzyk; M Kunicki; A Podfigurna-Stopa; L Plociennik; G Jakiel; M Maciejewska-Jeske; K Lukaszuk Journal: J Endocrinol Invest Date: 2016-06-14 Impact factor: 4.256